Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients [Phase 2]
A Phase 2 clinical trial evaluated metabolic cofactor supplementation in patients with Alzheimer's disease and Parkinson's disease; study st…
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Effect of Doxycycline in Levodopa Treated Parkinson's Disease Patients [Phase 2]
A Phase 2 clinical trial is investigating the effect of doxycycline in patients with Parkinson's disease treated with levodopa.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Physiological Flow of Liquids Used in Dysphagia Management (Neuro)
Completed clinical trial evaluating physiological flow of liquids used in dysphagia management in ALS and Parkinson disease patients; result…
-
CLINICAL_TRIALS trial_result · 2022-07-05Clinical Trial Update: Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease [Phase 2]
Phase 2 clinical trial evaluating imaging to monitor and predict progression in Parkinson disease. Completed study.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease [Phase 2]
Phase 2 trial assessing pridopidine vs placebo for safety and effectiveness in levodopa-induced dyskinesia in Parkinson's disease; study ter…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm [Phase 1, Phase 2]
A randomized clinical trial exploring modulation of GABA-A receptors using a flumazenil arm in Parkinson disease has completed Phase 1 and P…
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: EC50 of Dexmedetomidine in Deep Brain Stimulation Implantation of Patients With Parkinson's Disease [Phase 4]
Phase 4 trial update examining the EC50 of dexmedetomidine during deep brain stimulation implantation in patients with Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease [Phase 2]
Phase 2 trial updates the pharmacokinetics and pharmacodynamics of IPX203 in adults with advanced Parkinson's disease; results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Safety and Efficacy of DA-9805 for Parkinson's Disease [Phase 2]
Phase 2 trial results for DA-9805 in Parkinson's disease have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Apomorphine Effects on Pain in Parkinson's Disease [Phase 2, Phase 3]
A clinical trial update regarding apomorphine’s effects on pain in Parkinson’s disease across Phase 2 and Phase 3 is listed, with the status…
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Botulinum Toxin Type A for Foot Dystonia-associated Pain in Parkinson's Disease [Phase 2, Phase 3]
Clinical trial update on botulinum toxin type A for foot dystonia-associated pain in Parkinson's disease across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease [Phase 2]
Phase 2 clinical trial update for KDT-3594 in Japanese patients with early Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment [Phase 2]
Phase 2 study assessing safety of GRF6021 infusions in Parkinson's disease with cognitive impairment; trial completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease [Phase 2]
Phase 2 safety and biomarker study of PTC-589 in Parkinson's disease has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Efficacy of Oral Administration of Trehalose in Patients With Parkinson Disease [Phase 4]
Phase 4 trial evaluating the efficacy of oral trehalose in patients with Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients [Phase 2]
Phase 2 clinical trial assessing AVP-923 for levodopa-induced dyskinesia in Parkinson's disease completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Evaluation of the Infinity Deep Brain Stimulation Electrode Screening Mode Tool [NA]
A completed clinical trial evaluating the Infinity Deep Brain Stimulation electrode screening mode tool, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease [Phase 2]
Phase 2 clinical trial evaluating potential screening tools for detecting Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Bracing for Walking in Parkinson's Disease [NA]
Completed clinical trial investigating gait improvement strategies in Parkinson's disease; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: A Clinical Study of Efficacy, Safety, Tolerability and PK of ND0612H in Subjects With Advanced Parkinson's Disease [Phase 2]
Phase 2 clinical trial update on ND0612H for advanced Parkinson's disease assessing efficacy, safety, tolerability, and pharmacokinetics.
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: Cannabis Oil for Pain in Parkinson's Disease [Phase 2]
Phase 2 clinical trial investigating cannabis oil for pain in Parkinson's disease is in progress, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease [Phase 2, Phase 3]
A Phase 2/3 trial evaluating the effects of PR oxycodone and levodopa versus placebo on central neuropathic pain in Parkinson's disease has …
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation [Phase 2]
Phase 2 study of Venglustat (GZ/SAR402671) in Parkinson's disease patients with a GBA mutation was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Utilization of Target Ranges to Treat Parkinson's Disease With the PKG [NA]
Clinical trial update indicates termination for a Parkinson's disease study evaluating target ranges with PKG technology; results posted.